A Trial to Evaluate Safety and Tolerability of TST001 in Advanced or Metastatic Solid Tumors
Clinical trial NCT04396821 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04396821
- Sponsor
- Suzhou Transcenta Therapeutics Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-28
- Primary completion
- 2026-05-30
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.